IHS Chemical Week

Regions :: South America :: Brazil

Sanofi-Aventis to Acquire Top Brazilian Generics Firm for €500 million

1:07 AM MDT | April 9, 2009 | Deepti Ramesh

Sanofi-Aventis (Paris) says it has signed an agreement to acquire Medley (Campinas, Brazil), the leading generic player and the third largest pharmaceutical company in Brazil, for a total of about €500 million ($665 million). This acquisition will enable Sanofi-Aventis to become the leading player in the field of generics in Brazil and in Latin America, and it will also reinforce its number one ranking among pharmaceutical companies in Brazil, with a total 12% market share, Sanofi-Aventis says. The transaction is expected to close in the second quarter of...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa